Catalytic ferrous iron in amniotic fluid as a predictive marker of human maternal-fetal disorders

Journal of Clinical Biochemistry and Nutrition

Volumn 56, Issue 1, 2015, Pages 57-63

  Hattori, Yuka ^a   Mukaide, Takahiro ^a   Jiang, Li ^a   Kotani, Tomomi ^a   Tsuda, Hiroyuki ^a   Mano, Yukio ^a   Sumigama, Seiji ^a   Hirayama, Tasuku ^b   Nagasawa, Hideko ^b   Kikkawa, Fumitaka ^a   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Amniotic fluid; Catalytic ferrous iron; Oxidative stress; Pregnancy

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CATALYTIC FERROUS ION; FERROUS ION; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ADULT; AMNION FLUID; ARTICLE; BIRTH WEIGHT; BODY MASS; CESAREAN SECTION; CONCENTRATION (PARAMETERS); CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURE LABOR; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; TRISOMY 18;

EID: 84920404016     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.14-82     Document Type: Article

References (28)

1. Slonim DK, Koide K, Johnson KL, et al. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A 2009; 106: 9425-9429.
2. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol 2005; 25: 341-348.
3. Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 2002; 57: 609-613.
4. Hung TH, Lo LM, Chiu TH, et al. A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reprod Sci 2010; 17: 401-409.
5. Wang CN, Chen JY, Sabu S, et al. Elevated amniotic fluid F2-isoprostane: a potential predictive marker for preeclampsia. Free Radic Biol Med 2011; 50: 1124-1130.
6. Longini M, Perrone S, Kenanidis A, et al. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med 2005; 38: 1537-1541.
7. Perrone S, Longini M, Bellieni CV, et al. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007; 40: 177-180.
8. Escobar J, Teramo K, Stefanovic V, et al. Amniotic fluid oxidative and nitrosative stress biomarkers correlate with fetal chronic hypoxia in diabetic pregnancies. Neonatology 2013; 103: 193-198.
9. Patel M, Ramavataram DV. Non transferrin bound iron: nature, manifestations and analytical approaches for estimation. Indian J Clin Biochem 2012; 27: 322-332.
10. Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol 2013; 3: 315-330.
11. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 2009; 100: 9-16.
12. Weinberg ED. Are iron supplements appropriate for iron replete pregnant women? Med Hypotheses 2009; 73: 714-715.
13. Zein S, Rachidi S, Hininger-Favier I. Is oxidative stress induced by iron status associated with gestational diabetes mellitus? J Trace Elem Med Biol 2014; 28: 65-69.
14. Buonocore G, Perrone S, Longini M, et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003; 126: 1224-1230.
15. Gazzolo D, Perrone S, Paffetti P, et al. Non protein bound iron concentrations in amniotic fluid. Clin Biochem 2005; 38: 674-677.
16. Paffetti P, Perrone S, Longini M, et al. Non-protein-bound iron detection in small samples of biological fluids and tissues. Biol Trace Elem Res 2006; 112: 221-232.
17. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49: 91-102.
18. Malencik DA, Anderson SR. Dityrosine as a product of oxidative stress and fluorescent probe. Amino Acids 2003; 25: 233-247.
19. Kato Y, Wu X, Naito M, Nomura H, Kitamoto N, Osawa T. Immunochemical detection of protein dityrosine in atherosclerotic lesion of apo-E-deficient mice using a novel monoclonal antibody. Biochem Biophys Res Commun 2000; 275: 11-15.
20. Sun J, Sugiyama A, Masuda A, Ochi T, Takeuchi T. Expressions of protein oxidation markers, dityrosine and advanced oxidation protein products in acetaminophen-induced liver injury in rats. J Vet Med Sci 2011; 73: 1185-1190.
21. Itoh Y, Suzuki Y, Yamamoto T, Kojima K, Murakami I, Suzumori N. Increase in serum concentrations of inhibin in early onset pre-eclampsia with intrauterine growth restriction. J Obstet Gynaecol Res 2006; 32: 80-85.
22. Hirayama T, Okuda K, Nagasawa H. A highly selective turn-on fluorescent probe for iron(ii) to visualize labile iron in living cells. Chem Sci 2013; 4: 1250-1256.
23. Mukaide T, Hattori Y, Misawa N, et al. Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model. Free Radic Res 2014; 48: 990-995.
24. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-163.
25. Lam PM, Mistry V, Marczylo TH, Konje JC, Evans MD, Cooke MS. Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry. Free Radic Biol Med 2012; 52: 2057-2063.
26. Shimoi K, Kasai H, Yokota N, Toyokuni S, Kinae N. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2'-deoxyguanosine in human urine. Cancer Epidemiol Biomarkers Prev 2002; 11: 767-770.
27. Lurie S, Matas Z, Boaz M, Fux A, Golan A, Sadan O. Different Degrees of Fetal Oxidative Stress in Elective and Emergent Cesarean Section. Neonatology 2007; 92: 111-115.
28. Woods JR Jr, Cavanaugh JL, Norkus EP, Plessinger MA, Miller RK. The effect of labor on maternal and fetal vitamins C and E. Am J Obstet Gynecol 2002; 187: 1179-1183.